Terms: = Lung cancer AND HLF, Q16534, 3131, ENSG00000108924 AND Prognosis
8 results:
1. Construction of a genomic instability-derived predictive prognostic signature for non-small cell lung cancer patients.
Li W; Wu H; Xu J
Cancer Genet; 2023 Nov; 278-279():24-37. PubMed ID: 37579716
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a Four-Gene Signature Associated with the prognosis Prediction of lung Adenocarcinoma Based on Integrated Bioinformatics Analysis.
Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284
[TBL] [Abstract] [Full Text] [Related]
3. Integrative Molecular Analyses of an Individual Transcription Factor-Based Genomic Model for lung cancer prognosis.
Yao R; Zhou L; Guo Z; Zhang D; Zhang T
Dis Markers; 2021; 2021():5125643. PubMed ID: 34925645
[TBL] [Abstract] [Full Text] [Related]
4. Decreased hlf Expression Predicts Poor Survival in lung Adenocarcinoma.
Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z
Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320
[TBL] [Abstract] [Full Text] [Related]
5. Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma.
Huang J; Zhang Q; Shen J; Chen X; Ma S
Aging (Albany NY); 2021 Feb; 13(4):5946-5966. PubMed ID: 33612479
[TBL] [Abstract] [Full Text] [Related]
6. Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non-small cell lung cancer cells via Nrf2 inhibition.
Chen X; Wu Q; Chen Y; Zhang J; Li H; Yang Z; Yang Y; Deng Y; Zhang L; Liu B
Br J Pharmacol; 2019 Jun; 176(12):2079-2094. PubMed ID: 30825187
[TBL] [Abstract] [Full Text] [Related]
7. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
[TBL] [Abstract] [Full Text] [Related]
8. [Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
Hu YY; Sun XR; Lin XP; Liang PY; Zhang X; Fan W
Ai Zheng; 2009 Sep; 28(9):994-9. PubMed ID: 19728921
[TBL] [Abstract] [Full Text] [Related]
